SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MGI Pharma MOGN New patents, anti cancer -- Ignore unavailable to you. Want to Upgrade?

To: WTDEC who wrote (1013)5/21/1998 10:25:00 PM
From: adam hefian  Read Replies (1) | Respond to of 1826
 
I still am amazed at why a major brokerage firm has not picked up coverage of MOGN.Had the CFO not opened his mouth last Wednesday to the effect that he had no idea how MGI 114 worked,we would most probably be trading in the low 20s.The price is beginning to falter again.Hopefully if they announce the Phase 2 trials by next month,we could retest the highs we saw last week and might even go higher.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News